GoPubMed Proteins lists recent and important papers and reviews for
proteins. Page last changed on 19 Dec 2016.
Cancer antigen 1
CT3, Cancer Antigen, cancer/testis antigen gene
Sponsored links
Top mentioned proteins:
cardiotrophin-1, CT2, CAN, HAD, ACID
Papers on
CT3
HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survival.
New
Oslo, Norway. In Hum Pathol, Feb 2016
Higher HuR protein expression was associated with higher serum Cancer Antigen (CA) 125 levels at diagnosis (P=.01), but its presence at both cellular compartments was otherwise unrelated to clinicopathological parameters or survival.
Diagnostic Values of Carcinoembryonic Antigen, Cancer Antigen 15-3 and Cancer Antigen 125 Levels in Nipple Discharge.
New
Jinan, China. In Chin J Physiol, Jan 2016
The aim of this prospective study is to explore the utility of carcinoembryonic antigen, cancer antigen 15-3 and cancer antigen 125 levels in nipple discharge for the diagnosis of various breast diseases.
In vitro selection of RNA aptamers against CA125 tumor marker in ovarian cancer and its study by optical biosensing.
New
Roma, Italy. In Methods, Dec 2015
A well-known biomarker is the Cancer Antigen 125 (CA125) or 16 mucin (MUC 16), a glycoprotein of the human family of mucins, already used for the diagnostic and prognostic evaluation of ovarian cancer.
Preoperative Pelvic MRI and Serum Cancer Antigen-125: Selecting Women With Grade 1 Endometrial Cancer for Lymphadenectomy.
New
Madison, United States. In Ajr Am J Roentgenol, Nov 2015
OBJECTIVE: The objective of our study was to determine the predictive value of preoperative pelvic MRI and serum cancer antigen-125 (CA-125) evaluation in selecting women with grade 1 endometrial cancer for lymphadenectomy as part of the cancer staging operation.
Validity of Cancer Antigen-125 (CA-125) and Risk of Malignancy Index (RMI) in the Diagnosis of Ovarian Cancer.
New
Muscat, Oman. In Oman Med J, Nov 2015
OBJECTIVE: We sought to determine the validity of cancer antigen 125 (CA-125) and the risk of malignancy index (RMI) in the diagnosis of ovarian cancer in women presenting with adnexal lesions of various histopathology types.
Novel biomarkers and genomic tests in prostate cancer: a critical analysis.
New
Cleveland, United States. In Minerva Urol Nefrol, Sep 2015
PSA and derivatives (PSA kinetics, PSA density, percentage of free PSA) as well as algorithms based on PSA and PSA isoforms measurements (prostate health index, four-kallikrein score), urinary molecular biomarkers-based tests (Prostate Cancer Antigen 3, and the Michigan Health System Prostate Score) and selected genomic/proteomic tests now commercially available for disease prognostication (such as Confirm MDx, Prostate Core Mitomic Test, Oncotype DX, Prolaris, ProMark, and Decipher) are herein discussed to inform the readers about current and future clinical applications and their limitations.
Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series.
New
Madrid, Spain. In Clin Colorectal Cancer, Sep 2015
BACKGROUND: Providing adjuvant chemotherapy in locally advanced rectal cancer after neoadjuvant chemoradiation is currently a matter of debate.
Human Cancer Antigen Globo H Is a Cell-Surface Ligand for Human Ribonuclease 1.
New
Madison, United States. In Acs Cent Sci, Aug 2015
UNASSIGNED: Pancreatic-type ribonucleases are secretory enzymes that catalyze the cleavage of RNA.
Urinary Prostate Cancer Antigen 3 as a Tumour Marker: Biochemical and Clinical Aspects.
Review
Hamburg, Germany. In Adv Exp Med Biol, 2014
To overcome this weakness of PSA novel PCa biomarkers and detection tools are required.The urine-based biomarker Prostate Cancer Antigen 3 (PCA3) has been shown to be highly PCa-specific.
[Ovarian tumor markers of presumed benign ovarian tumors].
Review
Paris, France. In J Gynecol Obstet Biol Reprod (paris), 2013
Cancer Antigen 125 (CA125) and Human Epididymis Protein 4 (HE4) are the most studied ovarian tumor markers.
Serum markers of intrahepatic cholangiocarcinoma.
Review
Catania, Italy. In Dis Markers, 2012
The tumour markers used frequently such as Carbohydrate antigen 19-9 (CA 19-9), Carcinogenic Embryonic antigen (CEA), and Cancer Antigen 125 have shown sufficient sensitivity and specificity to detect and monitor CCA.
miRNAs as biomarkers in prostate cancer.
Review
Valencia, Spain. In Clin Transl Oncol, 2012
During last years, new promising biomarkers such as Prostate Cancer Antigen 3 (PCA-3) and TMPRSS2-ETS fusion genes have been evaluated for their clinical use.
Leiomyoma cellulare in the broad ligament of the uterus--case report and review of literature.
Review
Poznań, Poland. In Ginekol Pol, 2012
Cancer Antigen (CA) 125 level was 10.14 U/ml, beta sub-unit of human chorionic gonadotropin (beta- HOG) was 0.1 mIU/ml, acute-phase protein was (CRP) 0.09 mg/l.
High frequency of promoter methylation of the 14-3-3 sigma and CAGE-1 genes, but lack of hypermethylation of the caveolin-1 gene, in primary adenocarcinomas and signet ring cell carcinomas of the urinary bladder.
GeneRIF
Göttingen, Germany. In Int J Mol Med, 2007
The present data suggest that promoter methylation of the 14-3-3 sigma and CAGE-1 genes plays a crucial role during the phenotypical morphogenesis of vesical adenocarcinomas including signet ring cell carcinomas by an epigenetic mechanism.
Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients.
GeneRIF
São Paulo, Brazil. In Proc Natl Acad Sci U S A, 2006
CTSP-1 should be considered a promising candidate for cancer immunotherapy
Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
GeneRIF
Göttingen, Germany. In Int J Mol Med, 2006
The different patterns of aberrant methylation of the CAGE-1 gene in the various histopathological cancer types of the urinary bladder point to a role in tumor cell differentiation.
Should CA-125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma?
Impact
Copenhagen, Denmark. In J Clin Oncol, 2004
PURPOSE: The aim of the study was to compare the prognostic value of a response by the Gynecologic Cancer Intergroup (GCIG) Cancer Antigen (CA) -125 response criteria and the Response Evaluation Criteria in Solid Tumors (RECIST) on survival in patients with ovarian carcinoma receiving second-line chemotherapy.
Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.
Impact
Hannover, Germany. In Jama, 2003
CONTEXT: 1',1'dimethylheptyl-Delta8-tetrahydrocannabinol-11-oic acid (CT-3), a potent analog of THC-11-oic acid, produces marked antiallodynic and analgesic effects in animals without evoking the typical effects described in models of cannabinoids.
Identification and characterization of a novel cancer/testis antigen gene CAGE-1.
GeneRIF
Seoul, South Korea. In Biochim Biophys Acta, 2003
identification and characterization of CAGE-1 gene; displays testis-specific expression among normal tissues, and wide expression among various cancer tissues and cancer cell lines
